Skip to content
HowShorted

CorMedix Inc. short interest in 2025

In 2025, CorMedix Inc.'s disclosed short interest ran from 11.67% of shares outstanding on 15 Jan 2025 to 21.20% on 31 Dec 2025, a change of +9.53 percentage points. The year's high was 22.33% on 15 Sep 2025 and its low 11.67% on 15 Jan 2025, averaging 16.40% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 11.70 days on 14 Feb 2025. Full history: CorMedix Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for CorMedix Inc. in 2025

2025 in figures

Start of year
11.67% (15 Jan 2025)
End of year
21.20% (31 Dec 2025)
Change
+9.53 pp
High
22.33% (15 Sep 2025)
Low
11.67% (15 Jan 2025)
Average
16.40%
Highest days to cover
11.70 (14 Feb 2025)
SEC filings marked
11

Every report in 2025

CorMedix Inc. short interest in 2025
SettlementShort interestDays to coverFilings since previous
15 Jan 202511.67%4.23results (8-K)
31 Jan 202511.83%5.43
14 Feb 202512.18%11.70
28 Feb 202512.98%9.03
14 Mar 202513.48%10.85
31 Mar 202512.16%2.5410-K filed, results (8-K)
15 Apr 202512.67%5.42results (8-K)
30 Apr 202512.34%6.50
15 May 202512.96%2.7710-Q filed, results (8-K)
30 May 202513.09%7.44
13 Jun 202513.18%4.93
30 Jun 202514.81%3.22
15 Jul 202515.42%6.63
31 Jul 202516.38%5.05
15 Aug 202518.99%3.5510-Q filed, results (8-K)
29 Aug 202515.92%3.87
15 Sep 202522.33%2.76
30 Sep 202520.85%5.34
15 Oct 202521.67%8.07
31 Oct 202522.24%6.06results (8-K)
14 Nov 202522.14%4.9510-Q filed, results (8-K)
28 Nov 202521.68%6.26
15 Dec 202521.42%5.51
31 Dec 202521.20%7.34

See also: CorMedix Inc.'s full history · most shorted US stocks of 2025 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.